Work

Dosisanpassung von Upadacitinib bei mittelschwerer bis schwerer atopischer Dermatitis: Erkenntnisse aus einer multizentrischen Studie unter realen Bedingungen

Year: 2025

Type: article

Abstract: Jahren haben sich biologische Therapien und niedermolekulare Wirkstoffe, insbesondere Januskinase (

Source: JDDG Journal der Deutschen Dermatologischen Gesellschaft

DOI: 10.1111/ddg.15908_g

Authors: Flavia Manzo Margiotta, Valentina Dini, Laura Calabrese, Laura Lazzeri, Sofia Lo Conte, Manfredi Magliulo, Giulio Montesi, Leonardo Pescitelli, Nicola Milanesi, Carlo Mazzatenta, Emiliano Antiga, Pietro Rubegni, Massimo Gola, Marco Romanelli, Alessandra Cartocci

Institutions: University of Pisa, Scuola Superiore Sant'Anna, University of Siena, Azienda Ospedaliera Universitaria Senese, University of Florence, Ospedale San Giuseppe, Azienda Usl Toscana Centro, Azienda USL Toscana Nord Ovest

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,480

OpenAlex ID: W4417239371

FWCI:

Cites: 10

Cited by:

Related to: